Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

   

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2023

 

Commission File Number: 001-39034

 

 

BELLUS HEALTH INC.

(Translation of registrant’s name into English)

 

 

275 Armand-Frappier Blvd.

Laval, Québec

H7V 4A7

Canada

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ¨          Form 40-F x

 

 

  

 

 

 

 

DOCUMENTS FURNISHED AS PART OF THIS FORM 6-K

 

A Notice of Special Meeting of Shareholders

 

Form of Proxy for Registered Shareholders

  

Exhibits

 

99.1 – A Notice of Special Meeting of Shareholders

 

99.2 – Form of Proxy for Registered Shareholders

  

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	BELLUS Health Inc.
	(Registrant)
Date: June 6, 2023	By:	/s/ Ramzi Benamar
		Name:	Ramzi Benamar
		Title:	Chief Financial Officer